In conclusion, infusion of active caspase-3 to a level similar to that induced by NMDA treatment is sufficient to suppress synaptic transmission. We then performed similar experiments with recombinant BAD in its nonphosphorylated, active form. As shown in Figures 5A and Venetoclax supplier 5B, active caspase-3 was increased by 182 ± 18% at 1 hr of infusion (n = 5, p = 0.0001 for comparison of preinfusion and 1 hr of infusion), but when deactivated (boiled) BAD was used, active caspase-3 was increased only slightly (119 ± 7% of baseline at 1hr of infusion, n = 5, p = 0.058 for comparison of preinfusion and 1 hr of infusion). The cells infused with active BAD showed a run-down of EPSCs (76 ± 7% of baseline

at 1 hr of infusion, n = 9 slices from three mice, p = 0.013 for comparison of 2 min and 1 hr of infusion), while no such run-down was observed in cells infused with deactivated BAD or mutated BAD without the BH-3 domain through which BAD interacts with antiapoptotic BCL-2 family proteins (Youle and Strasser, 2008) (Figure 5D). The series resistance and input resistance were stable during the experimental period (Figures S4B and S4D), thus excluding cell death. Taken together, these data show that BAD and caspase-3 are sufficient to suppress synaptic currents. The above experiments established that BAD and BAX are required for caspase-3 activation and induction of LTD, but

not whether they act in a sequential or a parallel manner. To address this question, we selleck kinase inhibitor performed similar infusion experiments as above with hippocampal slices prepared from mice deficient in either caspase-3, BAX or BAD. As shown in Figure 5D, Chlormezanone although infusion of active BAD suppressed synaptic currents in wild-type neurons, it did not alter them significantly in caspase-3 knockout cells (92 ± 8% of baseline at 1 hr of infusion, n = 9 slices from three mice, p = 0.42 for comparison of 2 min and 1 hr of infusion). Likewise, BAD infusion had no significant effect on the EPSCs of BAX knockout cells (91 ± 7% of baseline at 1 hr of infusion,

n = 9 slices from three mice, p = 0.31 for comparison of 2 min and 1 hr of infusion). Again, the series resistance and input resistance remained constant during these infusion experiments (Figure S4). These results indicate that BAD requires BAX and caspase-3 to suppress synaptic transmission. Furthermore, the impairment of synaptic depression in BAD knockout and BAX knockout cells can be rescued by infusing active caspase-3 (EPSCs at 1 hr of infusion with active caspase-3 in BAD knockout cells: 46 ± 6% of baseline, n = 9 slices from three mice, p = 0.0001 for comparison of 2 min and 1 hr of infusion; in BAX knockout cells: 52 ± 5% of baseline, n = 9 slices from three mice, p = 0.0001 for comparison of 2 min and 1 hr of infusion; Figure 5C).